Cover Image
Market Research Report
Product code 
917679

Europe Multiplex Assay Market Forecast 2019-2027

Published: | Inkwood Research | 80 Pages | Delivery time: 2-3 business days

Price

Back to Top
Europe Multiplex Assay Market Forecast 2019-2027
Published: March 12, 2019
Inkwood Research
Content info: 80 Pages
Delivery time: 2-3 business days
  • ALL
  • Description
  • Table of Contents
Description

KEY FINDINGS

The European market region for the multiplex assay is expected to set a record CAGR of 7.24% during the forecast period of 2019-2027. Significant increase in research and development of drugs, new launches in the market, presence, and advancement of well- established healthcare systems are some of the factors estimated to result in the expansion of the market in the region.

MARKET INSIGHTS

The multiplex assay market of Europe is further segregated into the regions of Germany, France, the United Kingdom, Italy, Spain, and Rest of Europe. The market of Italy is expected to witness healthy growth in accordance with the rest of Europe owing to the recent developments in the regulatory policies and high unmet medical needs. The growing genetic and chronic disorders such as cancer, geriatric population, growing demand for personalized medicine, and the European Union's collective decision to streamline multiplex assay regulations will make the market grow in Spain.

The Rest of Europe includes Switzerland, Poland, Greece, Ukraine, Austria, Iceland, Ireland, Romania , among others, and the prominent regions here are Scandinavia and Benelux. Though in western Europe variations in reimbursement policies, lack of robust coverage and payment process is adversely affecting the adoption of new multiplex assay technology and creating an unpredictable market, the multiplex assay market of Scandinavia, Benelux, Switzerland, Poland and Ukraine is expected to grow because of the favorable regulations, high healthcare expenditure and universal healthcare coverage.

COMPETITIVE INSIGHTS

Some of the well-settled companies in the market which have global presence are Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Illumina, Inc., Becton, Dickinson and Company, among others.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 28496

Table of contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP-DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. NUCLEIC ACID-BASED MULTIPLEX ASSAYS ARE THE FASTEST GROWING TYPE
    • 3.2.2. REAGENTS AND CONSUMABLES ARE THE WIDELY USED PRODUCTS
    • 3.2.3. MULTIPLEX PCR IS THE VASTLY DEMANDING MULTIPLEX ASSAY TECHNOLOGY
    • 3.2.4. MULTIPLEX ASSAYS ARE HIGHLY ECONOMICAL ASSAY

4. MARKET DYNAMICS

  • 4.1. MARKET SCOPE & DEFINITION
  • 4.2. MARKET DRIVERS
    • 4.2.1. GROWING R&D ACTIVITIES & GOVERNMENTAL FUNDING
    • 4.2.2. PREFERENCE OF MULTIPLEX ASSAYS OVER CONVENTIONAL ASSAYS
    • 4.2.3. INCREASED IN THE ADOPTION OF PERSONALIZED MEDICINES
  • 4.3. MARKET RESTRAINTS
    • 4.3.1. LACK OF SKILLED PROFESSIONALS
  • 4.4. MARKET OPPORTUNITIES
    • 4.4.1. IDENTIFICATION OF NOVEL BIOMARKERS
  • 4.5. MARKET CHALLENGES
    • 4.5.1. STRINGENT REGULATIONS

5. MARKET BY TYPE

  • 5.1. PROTEIN-BASED MULTIPLEX ASSAYS
  • 5.2. NUCLEIC ACID-BASED MULTIPLEX ASSAYS
  • 5.3. OTHER MULTIPLEX ASSAYS

6. MARKET BY PRODUCT

  • 6.1. REAGENTS AND CONSUMABLES
  • 6.2. INSTRUMENTS AND ACCESSORIES
  • 6.3. SOFTWARE AND SERVICES

7. MARKET BY TECHNOLOGY

  • 7.1. MULTIPLEX PROTEIN MICROARRAY
  • 7.2. MULTIPLEX PCR
  • 7.3. OTHER TECHNOLOGY

8. MARKET BY APPLICATION

  • 8.1. CLINICAL DIAGNOSTICS
  • 8.2. RESEARCH AND DEVELOPMENT
  • 8.3. COMPANION DIAGNOSTICS

9. MARKET BY END-USER

  • 9.1. HOSPITALS
  • 9.2. CLINICAL LABORATORIES
  • 9.3. RESEARCH INSTITUTES
  • 9.4. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

10. KEY ANALYTICS

  • 10.1. PORTER'S FIVE FORCES MODEL
    • 10.1.1. THREAT OF NEW ENTRANTS
    • 10.1.2. THREAT OF SUBSTITUTE PRODUCTS
    • 10.1.3. BARGAINING POWER OF BUYER
    • 10.1.4. BARGAINING POWER OF SUPPLIER
    • 10.1.5. INTENSITY OF COMPETITIVE RIVALRY
  • 10.2. KEY BUYING CRITERIA
  • 10.3. KEY TRENDS
  • 10.4. OPPORTUNITY MATRIX

11. GEOGRAPHICAL ANALYSIS

  • 11.1. EUROPE
    • 11.1.1. GERMANY
    • 11.1.2. FRANCE
    • 11.1.3. THE UNITED KINGDOM
    • 11.1.4. ITALY
    • 11.1.5. SPAIN
    • 11.1.6. REST OF EUROPE

12. COMPETITIVE LANDSCAPE

  • 12.1. MARKET SHARE ANALYSIS
  • 12.2. COMPANY PROFILES
    • 12.2.1. ABCAM PLC.
    • 12.2.2. AGILENT TECHNOLOGIES, INC.
    • 12.2.3. BECTON DICKINSON AND COMPANY
    • 12.2.4. BIO-RAD LABORATORIES, INC.
    • 12.2.5. BIO-TECHNE CORPORATION
    • 12.2.6. ILLUMINA, INC
    • 12.2.7. LUMINEX CORPORATION
    • 12.2.8. MERCK MILIPORE
    • 12.2.9. MESO SCALE DIAGNOSTICS, LLC
    • 12.2.10. OLINK PROTEOMICS AB
    • 12.2.11. QIAGEN N.V.
    • 12.2.12. RANDOX LABORATORIES LTD.
    • 12.2.13. SEEGENE INC.
    • 12.2.14. SIEMENS HEALTHINEERS
    • 12.2.15. THERMO FISHER SCIENTIFIC INC.

LIST OF TABLES

  • TABLE 1: EUROPE MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)
  • TABLE 2: EUROPE MULTIPLEX ASSAY MARKET, BY TYPE, 2019-2027 ($ MILLION)
  • TABLE 3: EUROPE PROTEIN-BASED MULTIPLEX ASSAYS MARKET, 2019-2027 ($ MILLION)
  • TABLE 4: EUROPE NUCLEIC ACID-BASED MULTIPLEX ASSAYS MARKET, 2019-2027 ($ MILLION)
  • TABLE 5: EUROPE OTHER MULTIPLEX ASSAYS MARKET, 2019-2027 ($ MILLION)
  • TABLE 6: EUROPE MULTIPLEX ASSAY MARKET, BY PRODUCT, 2019-2027 ($ MILLION)
  • TABLE 7: EUROPE REAGENTS AND CONSUMABLES MARKET, 2019-2027 ($ MILLION)
  • TABLE 8: EUROPE INSTRUMENTS AND ACCESSORIES MARKET, 2019-2027 ($ MILLION)
  • TABLE 9: EUROPE SOFTWARE AND SERVICES MARKET, 2019-2027 ($ MILLION)
  • TABLE 10: EUROPE MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)
  • TABLE 11: EUROPE MULTIPLEX PROTEIN MICROARRAY MARKET, 2019-2027 ($ MILLION)
  • TABLE 12: EUROPE MULTIPLEX PCR MARKET, 2019-2027 ($ MILLION)
  • TABLE 13: EUROPE OTHER TECHNOLOGY MARKET, 2019-2027 ($ MILLION)
  • TABLE 14: EUROPE MULTIPLEX ASSAY MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
  • TABLE 15: EUROPE CLINICAL DIAGNOSTICS MARKET, 2019-2027 ($ MILLION)
  • TABLE 16: EUROPE RESEARCH AND DEVELOPMENT MARKET, 2019-2027 ($ MILLION)
  • TABLE 17: EUROPE COMPANION DIAGNOSTICS MARKET, 2019-2027 ($ MILLION)
  • TABLE 18: EUROPE MULTIPLEX ASSAY MARKET, BY END-USER, 2019-2027 ($ MILLION)
  • TABLE 19: EUROPE HOSPITALS MARKET, 2019-2027 ($ MILLION)
  • TABLE 20: EUROPE CLINICAL LABORATORIES MARKET, 2019-2027 ($ MILLION)
  • TABLE 21: EUROPE RESEARCH INSTITUTES MARKET, 2019-2027 ($ MILLION)
  • TABLE 22: EUROPE PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET, 2019-2027 ($ MILLION)
  • TABLE 23: EUROPE MULTIPLEX ASSAY MARKET, BY COUNTRY, 2019-2027 ($ MILLION)
  • TABLE 24: GERMANY MULTIPLEX ASSAY MARKET, BY TYPE, 2019-2027 ($ MILLION)
  • TABLE 25: GERMANY MULTIPLEX ASSAY MARKET, BY PRODUCT, 2019-2027 ($ MILLION)
  • TABLE 26: GERMANY MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)
  • TABLE 27: GERMANY MULTIPLEX ASSAY MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
  • TABLE 28: GERMANY MULTIPLEX ASSAY MARKET, BY END-USER, 2019-2027 ($ MILLION)
  • TABLE 29: FRANCE MULTIPLEX ASSAY MARKET, BY TYPE, 2019-2027 ($ MILLION)
  • TABLE 30: FRANCE MULTIPLEX ASSAY MARKET, BY PRODUCT, 2019-2027 ($ MILLION)
  • TABLE 31: FRANCE MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)
  • TABLE 32: FRANCE MULTIPLEX ASSAY MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
  • TABLE 33: FRANCE MULTIPLEX ASSAY MARKET, BY END-USER, 2019-2027 ($ MILLION)
  • TABLE 34: THE UNITED KINGDOM MULTIPLEX ASSAY MARKET, BY TYPE, 2019-2027 ($ MILLION)
  • TABLE 35: THE UNITED KINGDOM MULTIPLEX ASSAY MARKET, BY PRODUCT, 2019-2027 ($ MILLION)
  • TABLE 36: THE UNITED KINGDOM MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)
  • TABLE 37: THE UNITED KINGDOM MULTIPLEX ASSAY MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
  • TABLE 38: THE UNITED KINGDOM MULTIPLEX ASSAY MARKET, BY END-USER, 2019-2027 ($ MILLION)
  • TABLE 39: ITALY MULTIPLEX ASSAY MARKET, BY TYPE, 2019-2027 ($ MILLION)
  • TABLE 40: ITALY MULTIPLEX ASSAY MARKET, BY PRODUCT, 2019-2027 ($ MILLION)

LIST OF FIGURES

  • FIGURE 1: EUROPE MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)
  • FIGURE 2: EUROPE MULTIPLEX ASSAY MARKET SHARE, BY TYPE, 2018 & 2027 (%)
  • FIGURE 3: EUROPE MULTIPLEX ASSAY MARKET, BY PROTEIN-BASED MULTIPLEX ASSAYS, 2019-2027 ($ MILLION)
  • FIGURE 4: EUROPE MULTIPLEX ASSAY MARKET, BY NUCLEIC ACID-BASED MULTIPLEX ASSAYS, 2019-2027 ($ MILLION)
  • FIGURE 5: EUROPE MULTIPLEX ASSAY MARKET, BY OTHER MULTIPLEX ASSAYS, 2019-2027 ($ MILLION)
  • FIGURE 6: EUROPE MULTIPLEX ASSAY MARKET SHARE, BY PRODUCT, 2018 & 2027 (%)
  • FIGURE 7: EUROPE MULTIPLEX ASSAY MARKET, BY REAGENTS AND CONSUMABLES, 2019-2027 ($ MILLION)
  • FIGURE 8: EUROPE MULTIPLEX ASSAY MARKET, BY INSTRUMENTS AND ACCESSORIES, 2019-2027 ($ MILLION)
  • FIGURE 9: EUROPE MULTIPLEX ASSAY MARKET, BY SOFTWARE AND SERVICES, 2019-2027 ($ MILLION)
  • FIGURE 10: EUROPE MULTIPLEX ASSAY MARKET SHARE, BY TECHNOLOGY, 2018 & 2027 (%)
  • FIGURE 11: EUROPE MULTIPLEX ASSAY MARKET, BY MULTIPLEX PROTEIN MICROARRAY, 2019-2027 ($ MILLION)
  • FIGURE 12: EUROPE MULTIPLEX ASSAY MARKET, BY MULTIPLEX PCR, 2019-2027 ($ MILLION)
  • FIGURE 13: ADVANTAGES OF IMMUNOHISTOCHEMISTRY (IHC)
  • FIGURE 14: EUROPE MULTIPLEX ASSAY MARKET, BY OTHER TECHNOLOGY, 2019-2027 ($ MILLION)
  • FIGURE 15: EUROPE MULTIPLEX ASSAY MARKET SHARE, BY APPLICATION, 2018 & 2027 (%)
  • FIGURE 16: EUROPE MULTIPLEX ASSAY MARKET, BY CLINICAL DIAGNOSTICS, 2019-2027 ($ MILLION)
  • FIGURE 17: EUROPE MULTIPLEX ASSAY MARKET, BY RESEARCH AND DEVELOPMENT, 2019-2027 ($ MILLION)
  • FIGURE 18: EUROPE MULTIPLEX ASSAY MARKET, BY COMPANION DIAGNOSTICS, 2019-2027 ($ MILLION)
  • FIGURE 19: EUROPE MULTIPLEX ASSAY MARKET SHARE, BY END-USER, 2018 & 2027 (%)
  • FIGURE 20: EUROPE MULTIPLEX ASSAY MARKET, BY HOSPITALS, 2019-2027 ($ MILLION)
  • FIGURE 21: EUROPE MULTIPLEX ASSAY MARKET, BY CLINICAL LABORATORIES, 2019-2027 ($ MILLION)
  • FIGURE 22: EUROPE MULTIPLEX ASSAY MARKET, BY RESEARCH INSTITUTES, 2019-2027 ($ MILLION)
  • FIGURE 23: EUROPE MULTIPLEX ASSAY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2019-2027 ($ MILLION)
  • FIGURE 24: PORTER'S FIVE FORCE MODEL
  • FIGURE 25: KEY BUYING CRITERIA
  • FIGURE 26: NEWLY REGISTERED CLINICAL TRIAL STUDY 2016-2018
  • FIGURE 27: GERMANY MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)
  • FIGURE 28: FRANCE MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)
  • FIGURE 29: THE UNITED KINGDOM MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)
  • FIGURE 30: ITALY MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)
  • FIGURE 31: SPAIN MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)
  • FIGURE 32: REST OF EUROPE MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)
  • FIGURE 33: MULTIPLEX ASSAY COMPANY MARKET SHARE ANALYSIS 2018 (%)